Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) President Jon Christianson sold 1,991 shares of the company’s stock in a transaction dated Wednesday, January 28th. The shares were sold at an average price of $119.88, for a total transaction of $238,681.08. Following the transaction, the president directly owned 62,985 shares of the company’s stock, valued at $7,550,641.80. This represents a 3.06% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Jon Christianson also recently made the following trade(s):
- On Tuesday, December 23rd, Jon Christianson sold 1,691 shares of Palomar stock. The stock was sold at an average price of $139.50, for a total value of $235,894.50.
- On Tuesday, November 18th, Jon Christianson sold 522 shares of Palomar stock. The stock was sold at an average price of $128.84, for a total value of $67,254.48.
Palomar Trading Up 0.3%
PLMR stock traded up $0.38 during midday trading on Friday, hitting $123.59. The stock had a trading volume of 266,025 shares, compared to its average volume of 191,596. Palomar Holdings, Inc. has a 52 week low of $104.47 and a 52 week high of $175.85. The firm has a market capitalization of $3.28 billion, a price-to-earnings ratio of 19.28 and a beta of 0.42. The stock has a 50-day simple moving average of $127.64 and a 200 day simple moving average of $124.07.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of PLMR. Invesco Ltd. grew its holdings in Palomar by 234.1% during the 2nd quarter. Invesco Ltd. now owns 798,361 shares of the company’s stock worth $123,147,000 after acquiring an additional 559,383 shares during the period. Alliancebernstein L.P. grew its stake in shares of Palomar by 290.2% during the second quarter. Alliancebernstein L.P. now owns 497,080 shares of the company’s stock worth $76,675,000 after purchasing an additional 369,697 shares during the period. Westfield Capital Management Co. LP grew its stake in shares of Palomar by 81.0% during the third quarter. Westfield Capital Management Co. LP now owns 738,528 shares of the company’s stock worth $86,223,000 after purchasing an additional 330,592 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its holdings in Palomar by 72.1% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 785,165 shares of the company’s stock valued at $105,809,000 after purchasing an additional 328,993 shares during the last quarter. Finally, AustralianSuper Pty Ltd acquired a new position in Palomar in the second quarter valued at about $37,253,000. Institutional investors own 90.25% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on PLMR shares. Wall Street Zen upgraded shares of Palomar from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. JPMorgan Chase & Co. increased their price target on Palomar from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 7th. Keefe, Bruyette & Woods lifted their price objective on Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research report on Tuesday, January 6th. Finally, Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, January 14th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $159.50.
Get Our Latest Analysis on Palomar
About Palomar
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Featured Stories
- Five stocks we like better than Palomar
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- End of America update
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- What a Former CIA Agent Knows About the Coming Collapse
- Buy This Stock at 9:30 AM on MONDAY!
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
